Please Enable Cookies

www.cablinginstall.com is using a security service for protection against online attacks. This process is automatic. You will be redirected once the validation process is complete.

Recent Quotes
My Watchlist
Indicators
Cabling Market Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Natera, Inc. - Common Stock (NQ: NTRA )

167.61 -4.21 (-2.45%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 909,151
Open 171.80
Bid (Size) 165.00 (1)
Ask (Size) 174.20 (2)
Prev. Close 171.82
Today's Range 167.00 - 173.30
52wk Range 62.96 - 183.00
Shares Outstanding 132,020,816
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why the high growth investor may take a look at NATERA INC (NASDAQ:NTRA).
Exploring high growth characteristics of NATERA INC (NASDAQ:NTRA). A fundamental and technical analysis of (NASDAQ:NTRA). 
Via Chartmill
Natera to Present New Data at the 2025 ASCO GI Symposium
From Natera, Inc.
Via Business Wire

Performance

YTD
+4.36%
+4.36%
1 Month
+4.99%
+4.99%
3 Month
+42.44%
+42.44%
6 Month
+63.25%
+63.25%
1 Year
+159.38%
+159.38%

More News

Read More
Why Top 4% Guardant Health Surged To A 13-Month High And Topped A Profit-Taking Zone
Via Investor's Business Daily
Looking Into Natera's Recent Short Interest
Via Benzinga
Moderna, GameStop And Snap Are Among Top Large-Cap Losers Last Week (Jan 13-Jan 17): Are The Others In Your Portfolio?
Via Benzinga
The Analyst Verdict: Natera In The Eyes Of 14 Experts
Via Benzinga
Why NASDAQ:NTRA qualifies as a high growth stock.
Via Chartmill
Exploring NASDAQ:NTRA's high growth characteristics.
Via Chartmill
The End Of The 60/40 Portfolio
Via Benzinga
Topics Bonds
Exposures Debt Markets
Nvidia To Rally Around 31%? Here Are 10 Top Analyst Forecasts For Friday
Via Benzinga
Natera CEO Steve Chapman Recognized as a 2024 Top Healthcare Technology CEO and BioTechnology Innovator of the Year
From Natera, Inc.
Via Business Wire
Natera Announces Innovation Roadmap, with Advancements in MRD and Early Cancer Detection
From Natera, Inc.
Via Business Wire
Looking Into Natera's Recent Short Interest
Via Benzinga
Natera Announces Preliminary Fourth Quarter and Full-Year Results for 2024
From Natera, Inc.
Via Business Wire
Here Are Billionaire Stanley Druckenmiller's 5 Biggest Stock Holdings
Via The Motley Fool
Natera to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
From Natera, Inc.
Via Business Wire
Stanley Druckenmiller Dumps Street's Hottest AI Stocks — Here's What The Billionaire Investor Is Betting On Next
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Here Are Billionaire Stanley Druckenmiller's 5 Biggest Stock Holdings
Via The Motley Fool
Stanley Druckenmiller's Top Holding Has Outperformed Its Sector By 252%
Via Benzinga
Court Grants Natera’s Request to Include Additional Patent in its Lawsuit Against NeoGenomics
From Natera, Inc.
Via Business Wire
Natera Announces Enrollment of First Patients in SAGITTARIUS: a Randomized, Phase III Clinical Trial in Colon Cancer
From Natera, Inc.
Via Business Wire
Natera and MyOme Announce Launch of iPRS™ for Breast Cancer Risk Assessment
From Natera, Inc.
Via Business Wire
Clinical Validation Study on Natera’s Fetal RhD NIPT Published in Obstetrics & Gynecology
From Natera, Inc.
Via Business Wire
Natera Announces Medicare Coverage for Prospera™ in Single Lung Transplant Recipients
From Natera, Inc.
Via Business Wire
Natera to Present New SignateraTM Data in Multiple Abstracts at the San Antonio Breast Cancer Symposium
From Natera, Inc.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.